menu
    • menu

    Company profile for Alpha-9 Oncology

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alpha-9 Oncology is a clinical-stage radiopharmaceutical firm dedicated to enhancing cancer treatment. Through proprietary technologies and extensive expertise, Alpha-9 engineers tailored radiopharmaceuticals designed to precisely target tumor sites while minimizing collateral damage. With a focus on molecule design, Alpha-9 is developing a diverse pipeline of innovative radiopharmaceuticals, offering promising prospects for v...
    Alpha-9 Oncology is a clinical-stage radiopharmaceutical firm dedicated to enhancing cancer treatment. Through proprietary technologies and extensive expertise, Alpha-9 engineers tailored radiopharmaceuticals designed to precisely target tumor sites while minimizing collateral damage. With a focus on molecule design, Alpha-9 is developing a diverse pipeline of innovative radiopharmaceuticals, offering promising prospects for various oncology targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alpha-9 OncologyCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Vancouver, V5T 1M4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.a9oncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/a9oncology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alpha-9 Oncology Initiates Phase 1 Trial For A9-3408 In Melanoma
    Alpha-9 Oncology Initiates Phase 1 Trial For A9-3408 In Melanoma

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alpha-9-oncology-announces-first-patient-dosed-in-phase-1-study-of-a9-3408-for-the-treatment-of-melanoma-302632371.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Alpha-9 Oncology Names Paul Blanchfield at CEO
    Alpha-9 Oncology Names Paul Blanchfield at CEO

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alpha-9-oncology-appoints-paul-blanchfield-as-chief-executive-officer-302607905.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    ITM, Alpha-9 Oncology Sign Actinium-225 Supply Agreement
    ITM, Alpha-9 Oncology Sign Actinium-225 Supply Agreement

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067172/0/en/ITM-and-Alpha-9-Oncology-Enter-Into-Supply-Agreement-for-Therapeutic-Medical-Radioisotope-Actinium-225.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Alpha-9 Oncology Secures $175 Million For Clinical Pipeline
    Alpha-9 Oncology Secures $175 Million For Clinical Pipeline

    23 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alpha-9-oncology-inc-announces-175-million-oversubscribed-series-c-financing-to-advance-robust-clinical-pipeline-of-radiopharmaceuticals-302283806.html

    PR NEWSWIRE
    23 Oct 2024
    Share Share
    Alpha-9 Oncology Appoints Jean-Jacques and Dr. Steven to its BoD
    Alpha-9 Oncology Appoints Jean-Jacques and Dr. Steven to its BoD

    15 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alpha-9-oncology-appoints-jean-jacques-bienaime-and-dr-steven-stein-to-its-board-of-directors-302274361.html

    PR NEWSWIRE
    15 Oct 2024
    Share Share
    Alpha-9 Doses First Patient In Phase 1 A9-3202 Melanoma Study
    Alpha-9 Doses First Patient In Phase 1 A9-3202 Melanoma Study

    02 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alpha-9-oncology-announces-first-patient-dosed-in-phase-1-study-of-a9-3202-in-patients-with-locally-advanced-or-metastatic-melanoma-302133800.html

    PR NEWSWIRE
    02 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search